Diabetes Remission Roadmap | Reverse Type 2, Lower A1C, Medication-Free Living, Weight Loss
Brian & Cory
28 episodes
6 days ago
Breaking news for anyone on GLP-1 medications (Ozempic, Mounjaro, Wegovy): major patient assistance programs are being dropped for Medicare patients. In this emergency episode, Cory unpacks what this means, why it’s another wake-up call to stop outsourcing your health to a system built on profit, and how to protect yourself from skyrocketing costs and dependency. You’ll hear what’s really behind the decision, what patients should expect next, and why building strength, improving insulin sensi...
All content for Diabetes Remission Roadmap | Reverse Type 2, Lower A1C, Medication-Free Living, Weight Loss is the property of Brian & Cory and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Breaking news for anyone on GLP-1 medications (Ozempic, Mounjaro, Wegovy): major patient assistance programs are being dropped for Medicare patients. In this emergency episode, Cory unpacks what this means, why it’s another wake-up call to stop outsourcing your health to a system built on profit, and how to protect yourself from skyrocketing costs and dependency. You’ll hear what’s really behind the decision, what patients should expect next, and why building strength, improving insulin sensi...
#18 - CGMs 2.0: From Prescription-Only to OTC—What the New Sensors Mean for Type 2 Diabetes (and Beyond)
Diabetes Remission Roadmap | Reverse Type 2, Lower A1C, Medication-Free Living, Weight Loss
24 minutes
4 months ago
#18 - CGMs 2.0: From Prescription-Only to OTC—What the New Sensors Mean for Type 2 Diabetes (and Beyond)
Finger-sticks are so 2015. In this candid co-host convo, Brian and Cory unpack the game-changing arrival of over-the-counter continuous-glucose monitors—Dexcom Stelo, Abbott Libre Rio—and what they spell for anyone chasing diabetes remission. Inside the episode CGM 101 (in two minutes): time-in-range, glucose variability, and why A1C alone is yesterday’s news.OTC vs. Rx: how the new sensors slipped past the prescription gate, what they cost, and who can simply pick one up at the drugstore.Who...
Diabetes Remission Roadmap | Reverse Type 2, Lower A1C, Medication-Free Living, Weight Loss
Breaking news for anyone on GLP-1 medications (Ozempic, Mounjaro, Wegovy): major patient assistance programs are being dropped for Medicare patients. In this emergency episode, Cory unpacks what this means, why it’s another wake-up call to stop outsourcing your health to a system built on profit, and how to protect yourself from skyrocketing costs and dependency. You’ll hear what’s really behind the decision, what patients should expect next, and why building strength, improving insulin sensi...
